MUMBAI, India, Oct. 9 /PRNewswire/ -- Bilcare Limited, India’s leading pharma company in the drug discovery-to-market value chain, has acquired DHP Limited, a UK-based clinical trials service provider.
Commenting on this important acquisition, Mohan Bhandari, Chairman and Managing Director of Bilcare Limited said, “Bilcare has been successful in living up to its commitment of providing a truly worldwide operating network to the global pharmaceutical sector and partnering with them to enhance their speed-to-market by best in class local management of global clinical trials.”
Steven A. Jacobs, President of Bilcare, Inc. added, “This acquisition gives us the ability to fulfill global customers’ needs, providing quality support that enables them to manufacture, package, test, store and distribute clinical supplies in the EU. It also provides DHP Limited with the ability to do the same in the US and India, while adding a full range of analytical and Interactive Voice Response System (IVRS) capabilities to their clinical supply chain. The greatest achievement from this venture is the perfect alignment of quality systems, people, processes and values that both companies hold in high regard. Working together will be a seamless collaboration which is what customers are looking for in the clinical supplies and services industry.”
Based in Powys, UK DHP Limited specializes in the manufacture, import, storage and distribution of phase I-IV Investigational Medicinal Products and named patient/compassionate-use medicinal products. This includes a full range of Qualified Person (QP) services to support product lifecycles, from design through reconciliation and destruction. DHP Limited also provides GMP/GCP compliant services. Its clients include multinational pharmaceutical and biotech companies, leading Contract Research Organizations, publicly funded Medical Research Council (MRC) clinical research teams, plus National Health Service (NHS) trusts and hospitals. DHP Limited works in strict accordance with the EU Clinical Trials Directive plus other relevant regulations and licenses.
About Bilcare Limited
The Bilcare Limited goal is to be the leading partner and provider in the global life sciences sector from discovery to market with clinical trial services, packaging research, design and development plus formulation and analytical services.
The Clinical Supplies and Services business was established in India in early 2005. Bilcare Limited expanded with an acquisition in the USA that same year. The acquisition of DHP Limited in the UK is the next step in its strategy to become a leading market player with global clinical trial services capability. The UK facility will report in through the Clinical Supplies and Services USA Headquarters.
For more information on Bilcare products and services please visit http://www.bilcare.com. Contact: Steven Jacobs, President Phone: 800-310-4445 Fax: 610-935-4321 E-mail: direct-us@bilcare.com
Bilcare Limited
CONTACT: Steven Jacobs, President, of Bilcare Limited, +800-310-4445, Fax:+1-610-935-4321, direct-us@bilcare.com
Web site: http://www.bilcare.com/
